Behind the Paper

The real stories behind the latest research papers, from conception to publication, the highs and the lows.

Measuring the effect of Non-Pharmaceutical Interventions (NPIs) on mobility during the COVID-19 pandemic using global mobility data

Evaluating the efficacy of government interventions used to mitigate the spread of COVID-19 has been challenging. Mobility data from phones can be used as a low-cost and standardised mechanism to observe the change in the aggregate movement of populations in response to interventions stimuli.
Go to the profile of Amos Folarin
May 17, 2021

Behind the paper: Machine Learning for Patient Risk Stratification: Standing on, or looking over, the shoulders of clinicians?

Our recent publication, Machine Learning for Patient Risk Stratification: Standing on, or looking over, the shoulders of clinicians?, in npj Digital Medicine examines the question of whether clinical machine learning models truly extend beyond what clinicians already suspect.
Go to the profile of Brett Beaulieu-Jones +1
Brett Beaulieu-Jones and 1 other
Mar 31, 2021

Can clinically validated digital therapeutics and rigorous clinical science address longstanding treatment challenges to improving outcomes for children with ADHD?

In spite of dozens of existing treatment options, children with Attention Deficit Hyperactivity Disorder (ADHD) still fare poorly across many domains. We explore a new frontier in which digital therapeutics could help address these challenges for ADHD specifically and mental health more broadly.
Go to the profile of Scott Kollins
Mar 26, 2021